Saskia
Hendriks, MD, PhD
Bioethicist
301-435-8725
Dr. Saskia Hendriks is a bioethicist-physician with a focus on research ethics and the ethical, social and legal implications of emerging medical technologies.
BS, Amsterdam University College
MD, University of Amsterdam
PhD, Faculty of Medicine, University of Amsterdam
Dr. Hendriks is a faculty member in the NIH Department of Bioethics. She focuses on research ethics and the ethical, social and legal implications of emerging medical technologies, primarily within neuroscience and reproduction. Dr. Hendriks conducts theoretical/conceptual bioethics research. She also does interview and survey studies understand views of patients, professionals, and the general public on topics related to bioethics.
Dr. Hendriks has a joint appointment in the Neuroethics Program of the National Institute of Neurological Disorders and Stroke, where she serves as a faculty neuroethics consultant.
- NINDS Director's Award. For conceptualizing and launching the Neuroethics Consultation Service (with Dr. Khara Ramos), 2020
- NINDS Director's Award. For reestablishing and revitalizing a cross-cutting group focused on the intersection of data science and neuroscience in extramural NINDS (group award, 7 other awardees), 2020
- Residency at Brocher Foundation, 2016
Iyer AA, Saade D, Bharucha-Goebel DX, Foley AR, Averion G, Paredes E, Gray S, Bonnemann CG, Grady C, Hendriks S, Rid A. Ethical challenges Ethical Challenges for a New Wave of Early-Phase Pediatric Gene Therapy Trials. Genetics in Medicine, 2021;23(11): 2057-2066.
Hsu N*, Hendriks S*, Ramos KM, Grady C. Commentary: COVID-related adjustments to clinical research: ethical considerations for investigators. Nature Medicine 2021;27,191–193.
Hendriks S, Grady C, Wasserman D, Wendler D, Bianchi DW, Berkman B. A new ethical framework for assessing the unique challenges of fetal therapy trials. The American Journal of Bioethics, 2021, doi: 10.1080/15265161.2020.1867932 (Epub ahead of print).
Van Dijke I, van Wely M, Berkman B.E., Bredenoord A.L., Henneman L., Vliegenthart R., Repping S, Hendriks S. Should germline genome editing be allowed? The effect of treatment characteristics on public acceptability. Human Reproduction, 2020;36(2):465-478.
Hendriks S*, Grady C*, Ramos KM, Chiong W, Fins JJ, Ford P, Goering S, Greely HT, Hutchison K, Kelly ML, Kim SYH, Klein E, Lisanby SH, Mayberg H, Maslen H, Miller FG, Rommelfanger K, Sheth SA, Wexler A. Ethical Challenges of Risk, Informed Consent, and Posttrial Responsibilities in Human Research With Neural Devices: A Review. JAMA Neurology, 2019;76(12):1506–1514.
Hendriks S, van Wely M, D’Hooghe TMSH, Mol F, Meissner A. Peeraer K, Repping S, Dancet EAF. The relative importance of genetic parenthood. Reproductive Biomedicine Online, 2019;39(1):103-110.
Van Dijke I, Bosch L, Bredenoord AL, Cornel M, Repping S, Hendriks S. The ethics of clinical applications of germline genome modification: a systematic review of reasons. Human Reproduction, 2018;33(9):1777-1796.
Hendriks S, Vliegenthart R, Repping S, Dancet EAF. Broad support for regulating the clinical implementation of future reproductive techniques. Human Reproduction, 2018; 33(1): 39-46.
Hendriks S, Peeraer K, Bos H, Repping S, Dancet EAF. The importance of genetic parenthood for infertile men and women. Human Reproduction, 2017;39(10):2076–2087.
Hendriks S, Dancet EAF, van Pelt AM, Hamer G, Repping S. Artificial gametes: a systematic review of biological progress towards clinical application. Human Reproduction Update. 2015;21(3):285-296
* Authors contributed to this work equally.